Changes in Thymus Volume in Adult HIV-infected Patients Under HAART: Correlation with the T-cell Repopulation
Overview
Authors
Affiliations
An important thymus role has been suggested in T-cell repopulation after HAART in adult HIV-1 infected patients. Thymus volume increase after treatment has been described in HIV-1 infected children but not in adult patients. The objective of this work was to evaluate the effect of HAART on the thymic volume of adult HIV-1 infected patients and its relation with the T-cell repopulation. Twenty-one adult patients following 24 weeks under HAART were included in the study. All patients underwent a thoracic computed tomography (CT) evaluation for the measurement of thymic volumes at weeks 0, 12 and 24. Baseline thymus volume showed a significant correlation with the patient's age. Thymic volume significantly increased after 24 weeks of HAART. Besides, a significant correlation between changes in the thymus volume and changes in both total and naïve CD4+ cell counts was found. Only patients with increases > or =100 CD4+ cell counts after treatment significantly increased the thymic volume. These data show the first evidence of an early change in thymic volume of adult HIV-1 infected patients under HAART. This increase was related to the rise of both total and naïve CD4+ cell counts suggesting a functional role of thymic volume increase.
Endogenous thymic regeneration: restoring T cell production following injury.
Granadier D, Acenas 2nd D, Dudakov J Nat Rev Immunol. 2025; .
PMID: 39762553 DOI: 10.1038/s41577-024-01119-0.
Novak R, Armon C, Battalora L, Buchacz K, Li J, Ward D AIDS. 2022; 36(6):815-827.
PMID: 35013081 PMC: 11004734. DOI: 10.1097/QAD.0000000000003171.
Briceno O, Chavez-Torres M, Peralta-Prado A, Garrido-Rodriguez D, Romero-Mora K, Pinto-Cardoso S AIDS. 2019; 34(4):501-511.
PMID: 31794524 PMC: 7050791. DOI: 10.1097/QAD.0000000000002458.
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells.
Pinz K, Yakaboski E, Jares A, Liu H, Firor A, Chen K Oncotarget. 2018; 8(68):112783-112796.
PMID: 29348865 PMC: 5762550. DOI: 10.18632/oncotarget.22626.
Asiimwe S, Fatch R, Patts G, Winter M, Lloyd-Travaglini C, Emenyonu N AIDS Behav. 2017; 21(Suppl 2):204-215.
PMID: 28856539 PMC: 5660666. DOI: 10.1007/s10461-017-1895-2.